About: Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 April 2002

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у квітні 2002 (uk) article scientifique publié en 2002 (fr) im April 2002 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'abril de 2002 (ast) scientific article published on 01 April 2002 (en) գիտական հոդված հրատարակված 2002 թվականի ապրիլի 1-ին (hy)
publication date	wds:Q77844745-CC567587-70B0-460D-8075-12D9BF368EA5
publication date	2002-04-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q77844745-1355A6F0-B87B-411E-9515-07DA7FE5B8F6 wds:Q77844745-1F1EAFE4-ED44-4DDA-8E9F-0C486CE81AF7 wds:Q77844745-2F6B4960-E8AB-4D83-A25F-73D3271E2222 wds:Q77844745-426EB738-3083-4928-A58D-A3D2E74816F9 wds:Q77844745-4BE63D7A-F9D1-43FE-9A47-5C9E010DC8B6 wds:Q77844745-69D7D4EB-9C59-4275-929B-195507D12A61 wds:Q77844745-70519DE6-CAC9-4136-BD08-D6BD0CF19189 wds:Q77844745-7D0A54A9-582D-40D6-93C8-78F3FC094E03 wds:Q77844745-7D562C93-4BE2-47BE-B0BE-DB0E9EE1B26E wds:Q77844745-806A3D1C-724D-4EB1-A514-3FD9D6737E83 wds:Q77844745-9CD55A46-74BA-46BE-A04E-9F7A72C02027 wds:Q77844745-9EF5B1BE-C570-4317-BB5D-A380CAA45952 wds:Q77844745-AE9BAFC8-FF58-45F6-A2ED-FC6A87BCF161 wds:Q77844745-AF97AD93-3E6B-4239-A494-12EE2666CC2B wds:Q77844745-AFA95FB2-2ACB-47F0-A8F1-EDFC12D7D85F wds:Q77844745-BB8908F3-BB30-466C-89AB-85D6DC1EF9F5 wds:Q77844745-C0E99D76-EC90-4987-A992-63BC22BA1636 wds:Q77844745-C8ADBA0B-16FE-4BF4-AE89-3EDCA6B9848D wds:Q77844745-CAA54897-EFC8-454B-BC91-D14110238B91 wds:Q77844745-CBB648FA-EE18-488E-B3C1-A7F19BC6AC18 wds:Q77844745-D80B48D8-8B3A-4105-96C8-B4E7BB414001 wds:Q77844745-E6BCFDB7-891E-46A7-9868-3618CB4B073D wds:Q77844745-ED9A36A9-8407-4BD1-8185-4E1FF1BC588C wds:Q77844745-F01DACB6-DB59-49F4-9757-50AA19E699E8 wds:Q77844745-FBAA7416-D804-4A7E-8298-B591777CBAC0 wds:Q77844745-FC8F4F41-53C9-44CC-905B-E1DBB8DE15E0
cites work	Comparative degradation study of biodegradable microspheres of poly(DL-lactide-co-glycolide) with poly(ethyleneglycol) derivates Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders. A theoretical model of erosion and macromolecular drug release from biodegrading microspheres Polymers for sustained macromolecule release: procedures to fabricate reproducible delivery systems and control release kinetics Engineering the tissue which encapsulates subcutaneous implants. III. Effective tissue response times Biodegradable long-circulating polymeric nanospheres Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide) Engineering the tissue which encapsulates subcutaneous implants. II. Plasma-tissue exchange properties Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: Investigation of their drug encapsulation and release characteristics1 Stabilization of proteins encapsulated in cylindrical poly(lactide-co-glycolide) implants: mechanism of stabilization by basic additives Monitoring microviscosity and microacidity of the albumin microenvironment inside degrading microparticles from poly(lactide-co-glycolide) (PLG) or ABA-triblock polymers containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres Modulated release of IdUrd from poly (D,L-lactide-co-glycolide) microspheres by addition of poly (D,L-lactide) oligomers. Zero-order controlled-release polymer matrices for micro- and macromolecules Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins Utilization of poly(DL-lactide-co-glycolide) nanoparticles for preparation of mini-depot tablets by direct compression One-month sustained release microspheres of 125I-bovine calcitonin. In vitro-in vivo studies Ketoprofen-poly(D,L-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics pH and osmotic pressure inside biodegradable microspheres during erosion Formulation and release characteristics of poly(lactic-co-glycolic acid) microspheres containing chemically modified protein High-performance liquid chromatographic determination of dexamethasone in human plasma Analysis of theoretical behavior of a proposed zero-order drug delivery system. Optimization of the encapsulation and release of β-lactoglobulin entrapped poly(dl-lactide-co-glycolide) microspheres
author name string	wds:Q77844745-35B4D5DC-C986-448E-805D-52CD6481A360 wds:Q77844745-466F72DF-5E4A-4536-8AEF-4A872675923B wds:Q77844745-4D651856-DE2B-4B7D-936E-3CF464B97B83 wds:Q77844745-6C1121B7-5812-4E15-8AE0-88F732742055
author name string	T Hickey D J Burgess D Kreutzer F Moussy
rdfs:label	Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices (en) Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices (nl)
skos:prefLabel	Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices (en) Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices (nl)
name	Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices (en) Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices (nl)
title	wds:Q77844745-01E3D98A-4A54-49B2-B82D-47D3AE3EBCF1
title	Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices (en)
page(s)	wds:Q77844745-DAC6E60A-6559-4C54-9CE1-34E47B987094
page(s)	1649-1656
instance of	wds:Q77844745-83E5155C-CC3C-458B-B9D5-FCD7F67295B0
instance of	scholarly article
main subject	wds:Q77844745-95FAA4B3-90C9-48BA-BF6B-622159D73A2E wds:Q77844745-9C8A14E5-B8F8-476F-8EC6-53CCAB7ED8C0 wds:Q77844745-A748F9E5-62D2-4B76-BE37-1286F182E6F8
main subject	wd:Q422252 microsphere medical device
PubMed ID	wds:Q77844745-E84AB178-63AC-4106-AF0D-5F52FE2345D5
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11922468
PubMed ID	11922468
published in	wds:Q77844745-34A2D444-0CEE-4F71-B362-2F85DC046A3F
published in	Biomaterials
issue	wds:Q77844745-D51CAAB9-CDAE-403A-8452-F6A78A2765D7
volume	wds:Q77844745-2B10C0B0-A707-44CC-9BA5-C4078650745C
issue	7
volume	23
number of pages	wds:Q77844745-4976A2B1-D862-4742-9622-3344BA8CEF71
number of pages	8 (xsd:decimal)
DOI	wds:Q77844745-92EF1C90-105B-42F7-8C54-BD06D81D9778

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software